76075378

Information

• Trademark
• 76075378

• Source

• Serial Number

  76075378

• Registration Number

  2623068

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 3 - Bleaching preparations and other substances for laundry use
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  June 16, 2000
  24 years ago

• Registration Date

  September 24, 2002
  22 years ago

• Transaction Date

  June 23, 2009
  15 years ago

• Status Date

  May 16, 2009
  15 years ago

• Published for Opposition Date

  July 02, 2002
  22 years ago

• Location Date

  December 11, 2007
  17 years ago

• Status Code

  710

• Current Location

  SCANNING ON DEMAND

  Employee Name

  LEIPZIG, MARC J

• Attorney Name

  Michael A. Cantor

  Law Office Assigned Location Code

  M60

• Owners

  • MERISTEM THERAPEUTICS S.A

Case File Statements

• DM0000: The mark consists of a stylized design of a leaf with human features.
• GS0011: Chemicals for use in the manufacture of photographic materials, namely, paints, wetting agents, fixing agents, developing agents, and stabilizers; chemicals for use in the manufacture of paints, dyes, colorings, cosmetics, glues, and surfactants; chemicals for use in the manufacture of horticultural materials, namely, soil preparation agents and fertilizers; chemicals for use in the manufacture of hormones, peptides, enzymes, proteins in the nature of growth hormones for plants, animals and microbes and growth inhibitors and regulators; chemicals for use in the manufacture of diagnostic reagents, cell culture media, cell regulatory agents, amino acids, DNA fragments, RNA fragments, DNA probes, RNA probes, genetic cloning materials, and genetic expression amplifiers
• GS0031: Proteins for use as ingredients in skin lotions, oils and creams; for use as ingredients in sun tan lotions, oils and creams; for use as ingredients in skin hydrating lotions, oils and creams, namely, collagen, serum albumin, RNA, DNA and their extracts, amino acids, ribosomes, ceramides, immunostimulating or in imunoregulatory hormones, all obtained from plants; and enzymes for use as ingredients in skin lotions, oils and creams; for use as ingredients in sun tan lotions, oils and creams; for use as ingredients in skin hydrating lotions, oils and creams, namely, proteases, hydrolases, lipases, deshydroxylases and cellulases, all obtained from plants
• GS0051: Pharmaceutical preparations for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely human immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies; veterinary preparations for the treatment of rabies, obesity, auto-immune diseases, namely, feline immunodeficiency virus and simian immunodeficiency virus, in livestock, domestic pets and wild animals, namely foxes and rodents; acaricides, algaecides, biopesticides, herbicides, insecticides, miticides, pesticides and weed killers for agricultural, domestic or commercial use; pharmaceutical preparations produced from plants or containing proteins produced from plants, for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely human immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies; therapeutic proteins, hormones, peptides and their complexes, derivatives and cofactors, namely, human serum albumin, lactoferrin, hemoglobin, collagen and procollagen for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely human immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies; vaccines including antibodies or glycoproteins, namely, glycoprotein G, lipases, namely, gastric lipase, pancreatic lipase; and medicines and pharmaceutical preparations obtained from genetically modified plants or containing the extracts of genetically modified plants for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely human immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies
• GS0421: Biological and biotechnological laboratory research services, namely genetic modification of plants and plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings, biological and biochemical analysis of genetically modified plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings; laboratory research in the field of in-vitro reproduction and regeneration of genetically modified plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings; biological laboratory services in the field of in-vitro reproduction and regeneration of genetically modified plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings; laboratory research in the area of field and greenhouse reproduction of genetically modified plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings; biological laboratory services in the area of field and greenhouse reproduction of genetically modified plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings; laboratory research and tests regarding genetically modified plants; laboratory research featuring the expression of therapeutic, cosmetic or nutritional proteins or protein fragments through genetic modification, regeneration, and reproduction of plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings

Case File Event Statements

• 5/16/2009 - 15 years ago

  14 - CANCELLED SEC. 8 (6-YR) Type: C8..

• 2/18/2009 - 15 years ago

  13 - REVIEW OF CORRESPONDENCE COMPLETE Type: CORV

• 2/2/2009 - 15 years ago

  12 - PAPER RECEIVED Type: MAIL

• 12/11/2007 - 17 years ago

  11 - CASE FILE IN TICRS Type: CFIT

• 9/24/2002 - 22 years ago

  10 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 7/2/2002 - 22 years ago

  9 - PUBLISHED FOR OPPOSITION Type: PUBO

• 6/12/2002 - 22 years ago

  8 - NOTICE OF PUBLICATION Type: NPUB

• 1/30/2002 - 22 years ago

  7 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 11/5/2001 - 23 years ago

  6 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 7/5/2001 - 23 years ago

  5 - FINAL REFUSAL MAILED Type: CNFR

• 2/23/2001 - 23 years ago

  4 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 2/23/2001 - 23 years ago

  3 - Sec. 1(B) CLAIM DELETED Type: 1.BD

• 12/18/2000 - 24 years ago

  2 - NON-FINAL ACTION MAILED Type: CNRT

• 11/17/2000 - 24 years ago

  1 - ASSIGNED TO EXAMINER Type: DOCK